New Device will make TAVR procedure available to more patients
UNC’s Center for Heart & Vascular Care has been offering Transcatheter Aortic Valve Replacement (TAVR) for less than a year. In that time, the team has built a national reputation for excellence, allowing UNC to be among the first phase of the rollout of a next generation TAVR device, Evolut-R, developed by Medtronic. This valve is the first repositionable transcatheter valve ever available.
UNC Pulmonary Diseases and Critical Care Medicine: A Comprehensive ...
In the recent U.S. News and World Report rankings of America’s Best Hospitals, UNC Hospitals was nationally ranked in five of the 16 specialties. In this series, we profile these specialties to learn more about what makes them so outstanding.
UNC researchers find two biomarkers linked to severe heart disease
The finding published in PLoS One suggests that elevated oxidized LDL cholesterol and fructosamine – a measure of glycated proteins in blood sugar – are signposts for the development of severe coronary disease, especially in females.
Scientists find a key protein that allows Plavix to conquer platelets
The findings could lead to more personalized approaches to controlling platelet activity during heart attacks and other vascular emergencies and diseases. Wolfgang Bergmeier, PhD, professor of biochemistry and biophysics, member of the McAllister Heart Institute at UNC, is senior author of the paper.
New Ultrasound Device May Aid in Detecting Risk for Heart Attack, S...
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke.